Cargando…
The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer
Accumulating evidence suggests that dysregulation of transcriptional enhancers plays a significant role in cancer pathogenesis. Herein, we performed a genome-wide discovery of enhancer elements in colorectal cancer (CRC). We identified PVT1 locus as a previously unrecognized transcriptional regulato...
Autores principales: | Shigeyasu, Kunitoshi, Toden, Shusuke, Ozawa, Tsuyoshi, Matsuyama, Takatoshi, Nagasaka, Takeshi, Ishikawa, Toshiaki, Sahoo, Debashis, Ghosh, Pradipta, Uetake, Hiroyuki, Fujiwara, Toshiyoshi, Goel, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643275/ https://www.ncbi.nlm.nih.gov/pubmed/33148262 http://dx.doi.org/10.1186/s12943-020-01277-4 |
Ejemplares similares
-
SNORA21 – An Oncogenic Small Nucleolar RNA, with a Prognostic Biomarker Potential in Human Colorectal Cancer
por: Yoshida, Kazuhiro, et al.
Publicado: (2017) -
A metastasis‐associated microRNA‐based liquid biopsy signature for risk‐stratification in colorectal cancer: a multicenter cohort study
por: Matsuyama, Takatoshi, et al.
Publicado: (2022) -
Anorectal leiomyoma with GLUT1 overexpression mimicking malignancy on FDG-PET/CT
por: Teraishi, Fuminori, et al.
Publicado: (2022) -
Early detection of metachronous bile duct cancer in Lynch syndrome: report of a case
por: Shigeyasu, Kunitoshi, et al.
Publicado: (2013) -
Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer
por: Shigeyasu, Kunitoshi, et al.
Publicado: (2015)